Abstract
The extreme length of the DNA molecules in the nuclei of eukaryotic cells, as well as the possible attachment of the DNA to a structural matrix or scaffold in the nuclei, constrains the topology of the DNA helices. The topological constraint is that the two strands of a DNA helix are unable to change the number of turns of one strand about the other (the “linking number”, Lk), unless one or both strands are temporarily cut to form a gap through which other parts of the strands can pass. The topoisomerases provide mechanisms for such cutting and passing of strands, without which the DNA helix cannot unwind and replicated chromosomes cannot segregate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wang, J. C. DNA topoisomerases. Ann. Rev. Biochem. (1985) 54, 665–697.
Wang, J. C. Biochim. Biophys. Acta (1987) 909, 1–9.
Gellert, M. DNA topoisomerases. Ann. Rev. Biochem. (1981) 50, 979–910.
Liu, L. F. DNA topoisomerases: enzyme that catalyze the breaking and rejoining of DNA. CRC Critical Review in Biochemistry (1983) 15, 1–24.
Shelton, E. R., Osheroff, N., and Brutlag, D. L. DNA topoisomerase II from Drosphila melanogaster. Purification and physical characterization. J. Biol. Chem. (1983) 258, 9530–9535.
Liu, L. F., Rowe, T. C., Yang, L., Tewey, K. M., and Chen, G. L. Reversible DNA strand cleavage by mammalian DNA topoisomerase II. J. Biol. Chem. (1983) 258, 15365–15370.
Nelson, W. G., Pienta, K. J., Barrack, E. R., and Coffey, D. S. The role of the nuclear matrix in the organization and function of DNA. Ann. Rev. Biophys. Chem. (1986) 15, 457–475.
Earnshaw, W. C., Halligan, B., Cooke, C. A., Heck, M. M. S., and Liu, L. F. Topoisomerase II is a structural component of mitotic chromosome scaffolds. J. Cell Biol. (1985) 100, 1706–1715.
Gasser, S. M., Laroche, T., Falquet, J., Boy De La Tour, E., and Laemmli, U. K. Metaphase chromosome structure. Involvement of topoisomerase II. J. Mol. Biol. (1986) 188, 613–629.
Ross, W. E., Glaubiger, D. L., and Kohn, K. W. Qualitative and quantitative aspects of intercalator-induced DNA strand breaks. Biochim. Biophys. Acta (1979) 562, 41–50.
Zwelling, L. A., Michaels, S., Erickson, L. C., Ungerleider, R. S., Nichol, M., and Kohn, K. W. Protein-associated DNA strand breaks in L1210 cells treated with the DNA intercalating agent, 4’-(9-acridinylamino)methanesulfon-m-anisidide and adriamycin. Biochemistry (1981) 20, 6553–6563.
Pommier, Y., Mattern, M. R., Schwartz, R. E., and Zwelling, L. A. Absence of swivelling at sites of intercalator-induced protein-associated deoxyribonucleic acid strand breaks in mammalian cell nucleoids. Biochemistry (1984) 23, 2922–2927.
Pommier, Y., Mattern, M., Schwartz, R. E., Zwelling, L. A., and Kohn, K. W. Changes in deoxyribonucleic acid linking number due to treatment of mammalian cells with the intercalating agent, 4’-(9acridinylamino) methanesulfon-m-anisidide. Biochemistry (1984) 23, 2932, 2927.
Marshall, B., Ralph, R. K., and Hancock, R. Blocked 5’-termini in the fragments of chromosomal DNA produced in cells exposed to the antitumor drug 4’-(9-acridinylamino)methanesulphon-m-anisidide (m-AMSA). Nucleic Acids Res. (1983) 11, 4251–4256.
Long, B. H., Musial, S. T., and Brattain, M. G. Comparison of cytotoxicity and DNA breakage activity of congeners of podophyllotoxin including VP16–213 and VM-26: A quantitative structure-activity relationship. Biochemistry (1984) 23, 1183–1188.
Wozniak, A. J., and Ross, W. E. DNA damage as a basis for 4’-demethylepipodophyllotoxin-9-(4,6–0-ethylidene- -D-glucopyranoside)(Etoposide) cytotoxicity. Cancer Res. (1983) 43, 120–124.
Pommier, Y., Kerrigan, D., Schwartz, R., and Zwelling, L. A. The formation and resealing of intercalator-induced DNA strand breaks in isolated L1210 cell nuclei. Biochem. Biophys. Res. Commun. (1982) 107, 576–583.
Filipski, J. and Kohn, K. W. Ellipticine-induced protein-associated DNA breaks in isolated L1210 nuclei. Biochim. Biophys. Acta (1982) 698, 280–286.
Pommier, Y., Schwartz, R. E., Kohn, K. W., and Zwelling, L. A. Formation and rejoining of deoxyribonucleic acid double-strand breaks produced in isolated cell nuclei by antineoplastic antitumor intercalating agents. Biochemistry (1984) 23, 2927–2932.
Tewey, K. M., Rowe, T. C., Yang, L., Halligan, B. D., and Liu, L. F. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science (1984) 226, 466–468.
Minford, J., Pommier, Y., Filipski, J., Kohn, K. W., Kerrigan, D., Mattern, M., Michaels, S., Schwartz, R., and Zwelling, L. A. Isolation of intercalator-dependent protein-linked DNA strand cleavage activity from cell nuclei and identification as DNA topoisomerase II. Biochemistry (1986) 25, 9–16.
Kohn, K. W., Ewig, R. A. G., Erickson, L. C., and Zwelling, L. A. Measurement of DNA strand breaks and crosslinks by alkaline elution. In: E. C. Friedberg and P. C. Hanawalt (eds.). DNA Repair. A Laboratory Manual of Research Techniques. pp. 379–401. New York: Marcel Dekker, 1981.
Zwelling, L. A., Michaels, S., Kerrigan, D., Pommier, Y., and Kohn, K. W. Protein-associated deoxyribonucleic acid strand breaks produced in mouse leukemia L1210 cells by ellipticine and 2-methyl-9-hydroxyellipticinium. Biochem. Pharmacol. (1982) 31, 3261–3267.
Pommier, Y., Zwelling, L. A., Mattern, M. R., Erickson, L. C., Kerrigan, D., and Kohn, K. W. Effects of dimethyl sulfoxide and thiourea upon intercalator-induced DNA strand breaks in mouse leukemia (L1210) cells. Cancer Res. (1983) 43, 5718–5724.
Kerrigan, D., Pommier, Y., and Kohn, K. W. Protein-linked DNA strand breaks produced by etoposide (VP-16) and teniposide (VM-26) in mouse L1210, and human VA-13 and HT-29 cell lines. Relationship to cytotoxicity. Proceeding of the First Conference on DNA Topoisomerases in Cancer Chemotherapy. NCI Monograph (1987) 4, 117–121.
Cook, P. R. and Brazell, I. A. Conformation constraints in nuclear DNA. J. Cell Sci. (1976) 22, 287–302.
Mattern, M. R. and Painter, R. B. Dependence of mammalian DNA replication on DNA supercoiling. I. Effect of ethidium bromide on DNA synthesis in permeable Chinese hamster ovary cells. Biochim. Biophys. Acta (1979) 563, 293–305.
Marini, J. C., Miller, K. G., and Englund, P. T. Decatenation of kinetoplast DNA by topoisomerase II. J. Biol. Chem. (1980) 255, 4976–4979.
Liu, L. F., and Davis, J. L., and Calendar, R. Novel topologically knotted DNA from bacteriophage P4 capsids: Studies with DNA topoisomerases. Nucleic Acid Res. (1981) 9, 3979–3989.
Kohn, K. W., Pommier, Y., Kerrigan, D., Markovits, J., and Covey, J. Topoisomerase II as a target of anticancer drug action in mammalian cells. Proceedings of the First Conference on Topoisomerases in Cancer Chemotherapy, NCI Monograph (1987) 4, 61–71.
Yang, L., Rowe, T. C., and Liu, L. F. Identification of DNA topoisomerase II as an intracellular target of antitumor epipodophyllotoxins in Simian virus 40-infected monkey cells. Cancer Res. (1985) 45, 5872–5876.
Pommier, Y., Minford, J. K., Schwartz, R. E., Zwelling, L. A., and Kohn, K. W. Effects of the DNA intercalators 4’-(9-acridinylamino) methanesulfon-m-anisidide and 2-methyl-9-hydroxyellipticinium on topoisomerase II-mediated DNA strand cleavage and strand passage. Biochemistry (1985) 24, 6410–6416.
Chen, G. L., Yang, L., Rowe, T. C., Halligan, B. D., Tewey, K. M., and Liu, L. F. Non-intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. (1985) 259, 13560–13566.
Long, B. H., Musial, S. T., and Brattain, M. G. Single-and double-strand DNA breakage and repair in human lung adenocarcinoma cells exposed to etoposide and teniposide. Cancer Res. (1985) 45, 3106–3112.
Pommier, Y., Covey, J., Kerrigan, D., Mattes, W., Markovits, J., and Kohn, K. W. Role of DNA intercalation in the inhibition of purified mouse leukemia (L1210) DNA topoisomerase II by 9-aminoacridines. Biochem. Pharmacol. (1987) 36, 3477–3486.
Tewey, K. M., Chen, G. L., Nelson, E. M., and Liu. L. F. Intercalative antitumor drugs interfere with the breakage-reunion reaction of mammalian DNA topoisomerase II. J. Biol. Chem. (1984) 259, 9182–9187.
Pommier, Y., Covey, J. M., Kerrigan, D., Markovits, J., and Pham, R. DNA unwinding and inhibition of mouse leukemia L1210 DNA topoisomerase I by intercalators. Nucl. Acids Res. (1987) 15, 6713–6731.
Denny, W. A., and Wakelin, L. P. G. Kinetic and equilibrium studies of the interaction of amsacrine and anilino ring-substituted analogs with DNA. Cancer Res. (1986) 46, 1717–1721.
Rowe, T., Kukpper, G., and Ross, W. Inhibition of epipodophyllotoxin cytotoxicity by interference with topoisomerase-mediated DNA cleavage. Biochem. Pharmacol. (1985) 14, 2483–2487.
Markovits, J., Pommier, Y., Mattern, M. R., Esnault, C., Roques, B. P., Le Pecq, J. B., and Kohn, K. W. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II. Cancer Res. (1986) 46, 5821–5826.
Sander, M. and Hsieh, T. S. Drosophilia topoisomerase II double-strand DNA cleavage: analysis of DNA sequence homology at the cleavage site. Nucleic Acids Res. (1985) 13, 1057–1071.
Riou, J. F., Gabillot, M., Phielippe, M., Schrevel, J., and Riou, G. Purification and characterization of plasmodium berghei DNA topoisomerases I and II: Drug action, inhibition of decatenation and relaxation, and stimulation of DNA cleavage. Biochemistry (1986) 25, 1471–1476.
Vilarem, J. J., Riou, J. F., Multon, E., Grass, M. P., and Larsen, C. J. The in vitro involvement of topoisomerase II in the activity of aza-ellipticine analogues is not correlated with drug activity in isolated nuclei. Biochem. Pharmacol. (1986) 35, 2087–2095.
Zwelling, L. A., Kerrigan, D., Michaels, S., and Kohn, K. W. Cooperative sequestration of m-AMSA in L1210 cells. Biochem. Pharmacol. (1982) 31, 3269–3277.
Smith, P. J., Anderson, C. O., and Watson, J. V. Predominant role for DNA damage in etoposide-induced cytotoxicity and cell cycle perturbation in human SV40-transformed fibroblasts. Cancer Res. (1986) 46, 5641–5645.
Kalwinsky, D. K., Look, A. T., Ducore, J., and Fridland, A. Effects of the epipodophyllotoxin VP-16–213 on cell cycle traverse, DNA synthesis and DNA strand size in cultures of human leukemic lymphoblasts. Cancer Res. (1983) 43, 1592–1597.
Pommier, Y., Zwelling, L. A., Shan, C. S., Whang-Peng, J., and Bradley, M. O. Correlation between intercalator-induced DNA strand breaks, sister chromatid exchanges, mutations and cytotoxicity in Chinese hamster cells. Cancer Res. 45, 3143–3149, 1984.
Pommier, Y., Kerrigan, D., and Kohn, K. W. Topoisomerase II alterations associated with drug resistance in a line of chinese hamster cells. Proceeding of the First Conference on Topoisomerases in Cancer Chemotherapy. NCI Monograph (1987) 4, 83–87.
Sullivan, D. M., Glisson, B. S., Hodges, P. K., Smallwood-Kentro, S., and Ross, W. E. Proliferation dependence of topoisomerase II mediated drug action. Biochemistry (1986) 25, 2248–2256.
Zwelling, L. A., Estey, E., Silberman, L., Doyle, S., and Hittelman, W. Effect of Cell proliferation and chromatin conformation on intercalatorinduced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts. Cancer Res. (1987) 47, 251–257.
Markovits, J., Pommier, Y., Kerrigan, n., Covey, J., Tilchen, E. J., and Kohn, K. W. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle. Cancer Res. (1987) 47, 2050–2055.
Duguet, M., Lavenot, C., Harper, F., Mirambeau, G., and DeRecondo, A. M. DNA topoisomerases from rat liver: physiological variations. Nucl. Acids Res. (1985) 11, 1059–1075.
Taudou, G., Mirambeau, G., Lavenot, C., Der Garabedian, A., Vermaersch, J., and Duguet, M. DNA topoisomerase activities in concanavaline A-stimulated lymphocytes. FEBS (1984) 176, 431–435.
Nelson, W. G., Liu, L. F., and Coffey, D. S. Newly replicated DNA is associated with DNA topoisomerase II in cultured rat prostatic adenocarcinoma cells. Nature (1986) 322, 187–189.
Holm, C., Goto, T., Wang, J. C., and Boldstein, D. DNA topoisomerase II is required at the time of mitosis in yeast. Cell (1985) 41, 553–563.
Yemura, T. and Yanagida, M. Mitotic spindle pulls but fails to separate chromosomes in type II DNA topoisomerase mutants: uncoordiated mitosis. EMBO J. (1986) 5, 1003–1010.
DiNardo, S., Voelkel, K., and Sternglanz, R. DNA topoisomerases II mutant of Saccharomyces cerevisiae: Topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication. Proc. Natl. Acad. Sci. USA (1984) 81, 2616–2620.
Painter, R. B. A replication model for sister chromatid exchanges. In: Sister Chromatid Exchange (1982) pp. 115–121. New York:Alan Liss.
Ikeda, H. Bacteriophage T4 DNA topoisomerase mediates illegitimate recombination in vitro. Proc. Natl. Acad. Sci. USA (1986) 83, 922–926.
Huang, C. C., How, Y., and Wang, J. J. Effects of a new antitumor agent, epipodophyllotoxin, on growth and chromosomes in human
Hsu, T. C., Pathank, S., and Kusyk, C. Continuous induction of chromatin lesions by DNA intercalating compounds. Mut. Res. (1975) 33, 417–420.
Pommier, Y., Kerrigan, D., Covey, J. M., Kao-Shan, C. S., and Whang-Peng, J. Sister chromatid exchanges, chromosonal aberrations, and cytotoxicity produced by antitumor topoisomerase II inhibitors in sensitive (DC3F) and resistant (DC3F/9-OHE) chinese hamster cells. Cancer Res. (1987) 48, 512–516.
Rowe, T. C., Chen. G. L., and Hsiang, Y.-H. and Liu, L. F. DNA damage by antitumor acridines mediated by mammalian DNA topoisomerase II. Cancer Res. (1986) 46, 2021–2026.
Covey, J. M., Kohn, K. W., Kerrigan, D., Tilchen, E. J., and Pommier, Y. Topoisomerase II-mediated DNA damage produced by 4’-(9-acridinylamino)methanesulfon-m-anisidide and related acridines in L1210 cells and isolated nuclei: relation to cytotoxicity. Cancer Res. (1987) 48, 860–865.
Salles, B., Charcosset, J. Y., and Jacquemin-Sablon, A. Isolation and properties of Chinese hamster lung cells resistant to ellipticine derivatives. Cancer Treat. Rep. (1982) 66, 327–338.
Charcosset, J. Y., Salles, B., and Jacquemin-Sablon, A. Uptake and Cytofluorescence localization of ellipticine derivatives in sensitive and resistant Chinese hamster lung cells. Biochem. Pharmacol. (1983) 32, 1037–1044.
Charcosset, J. Y., Bendirdjian, J. P., Lantiere, M. F., and JacqueminSablon, A. Effects of 9–0H-ellipticine on cell survival, macromolecular syntheses, and cell cycle progression in sensitive and resistant chinese hamster lung cells. Cancer Res. (1983) 45, 4229–4236.
Gupta, R. S. Genetic, biochemical, and cross-resistance studies with mutants of Chinese hamster ovary cells resistant to the anticancer drugs, VM-26 and VP-16–213. Cancer Res. (1983) 43, 1568–1574.
Johnson, R. K. and Howard, W. S. Development and cross resistance characteristics of a subline of P388 leukemia resistant to 4’-(9acridinylamino)methanesulfon-m-anisidide. Eur. J. Cancer Clin. Oncol. (1982) 31, 3008–3010.
Kessel, D., Wheeler, C., Chou, T. H., Howard, W. S., and Johnson, R. K. Studies on a mode of resistance to m-AMSA. Biochem. Pharmacol. (1982) 31, 3008–3010.
Goldenberg, G., J., Wang, H., and Blair, G. W. Resistance to adriamycin: relationship to cytotoxicity to drug uptake and DNA single-and double-strand breakage in cloned cell lines of adriamycinsensitive and -resistant P388 leukemia. Cancer Res. (1986) 46, 2978–2983.
Zijlstra, J. G., de Vries, E. G. E., and Mulder, N. H. Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. (1987) 47, 1780–1784.
Dank, M. K., Yalowich, J. C., and Beck, W. T. Atypical multiple drug resistance in a human leukemic cell line selected for resistance to teniposide (VM26). Cancer Res. (1987) 47, 1297–1301.
Odaimi, M., Andersson, B. S., McCredie, K. B., and Beran, M. Drug sensitivity and cross-resistance of the 4’-(9-acridinylamino) methanesulfon-m-anisidide-resistant subline of HL-60 human leukemia. Cancer Res. (1986) 46, 330–3333.
Marsh, W., Sicheri, D., and Center, M. S. Isolation and characterization of adriamycin-resistant HL-60 cells which are not defective in the initial accumulation of drug. Cancer Res. (1986) 46, 4053–4057.
Long, B. H., Musial, S. T., and Brattain, M. G. DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide. Cancer Res. (1986) 46, 3809–3816.
Pommier, Y., Schwartz, R., Zwelling, L. A., Kerrigan, D., Mattern, M. R., Charcosset, J. Y., Jacquemin-Sablon, A., and Kohn, K. W. Reduced formation of protein-associated DNA strand breaks in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res. (1986) 46, 611–616.
Glisson, B., Gupta, R., Smallwookd-Kentro, S., and Ross. W. Characterization of acquired epipodophyllotoxins resistance in a Chinese hamster ovary cell line: Loss of drug-stimulated DNA cleavage activity. Cancer Res. (1986) 46, 1934–1938.
Bakic, M., Beran, M., Anderson, B. S., Silberman, L, Estey, E., and Zwelling, L. A. The production of topioisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4-’ (9-acridinylamino)methanesulfon-m-anisidide (m-AMSA). Biochem. Biophys. Res. Comm. (1986) 134, 638–645.
Pommier, Y., Kerrigan, D., Schwartz, R., Swack, J., and McCurdy, A. Altered topoisomerase II activity in Chinese hamster cells resistant to topoisomerase II inhibitors. Cancer Res. (1986) 46, 3075–3081.
Glisson, B., Gupta, R., Hodges, P., and Ross. W. Cross-resistance to intercalating agents in an epipodophyllotoxin-resistant Chinese hamster ovary cell line: Evidence for a common intracellular target. Cancer Res. (1986) 46, 1939–1942.
Sullivan, D. and Ross, W. E. Purification and characterization of a topoisomerase II mutant from epipodophyllotoxin-resistant Vpm -5 cells. Proceedings of the Am. Assoc. Cancer Res. (1987) 28, 293.
Robson, C. N., Hoban, P. R., Harris, A. L., and Hickson, I. D. Cross-sensitivity to topoisomerase II inhibitors in cytotoxic drug-hypersensitve Chinese hamster ovary cell lines. Cancer Res. (1987) 47, 1540–1565.
Kupfer, G., Bodley, A. L., and Liu, L. F. Involvement of intracellular ATP in cytotoxicity of topoisomerase II-targetting antitumor drugs. First Conference on DNA topoisomerases in Cancer Chemotherapy. NCI Monograph (1987) 4, 37–40.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Springer Science+Business Media New York
About this chapter
Cite this chapter
Pommier, Y., Kerrigan, D., Jaxel, C., Covey, J.M., Ulhenhopp, E., Mattern, M.R. (1989). Antineoplastic Agents Inhibitor of Topoisomerase II. In: Castellani, A. (eds) DNA Damage and Repair. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-5016-4_24
Download citation
DOI: https://doi.org/10.1007/978-1-4757-5016-4_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-5018-8
Online ISBN: 978-1-4757-5016-4
eBook Packages: Springer Book Archive